跳至主要内容
临床试验/JPRN-UMIN000050420
JPRN-UMIN000050420已完成Unknown

Clinical pharmacological test of calcium alginate capsules. -Optimization study of postprandial serum triglyceride elevation suppression effect (preliminary study)- - Optimization test of postprandial serum triglyceride elevation suppression effect of calcium alginate capsules (preliminary test).

Takasaki University of Health and Welfare0 个研究点目标入组 6 人开始时间: 2023年2月25日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Those who are taking dyslipidemia drugs. (Persons receiving treatment for hyperlipidemia) If the participant has some kind of disease and is under medication, and the cooperating doctor deems the participant unsuitable as a subject. Subjects who may have allergic symptoms to rubber or latex. Subjects who may have allergic symptoms to corn oil. If any of the results of HIV antigen/antibody, HBV, HCV, and syphilis tests at screening are positive. Subjects with obvious abnormalities in hematological and biochemical tests. Those who are pregnant, those who wish to become pregnant during the test, and those who are breastfeeding.

研究者

相似试验